For patients with Type 2 diabetes, GLP-1 medicines have become well-established treatments due in part to continued innovation within the class and increased utilization. She said the company has invested about $1.6 billion this year to expand production capacity, adding, We take this situation very seriously and are doing everything we can to be able to meet demand as fast as possible.
Discontinuation rates due to adverse events were higher in the active treatment groups compared with placebo, particularly at higher doses, though the overall discontinuation rate remained relatively modest
If nothing else is working for you, your doctor will make recommendations
Do not exceed the recommended daily serving stated on the product label
At present, the main treatment methods for myopenia include nutritional intervention, resistance training, drug therapy, and comprehensive management strategies [10]